| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Cue Biopharma Inc (NASDAQ: CUE)
CUE Technical Analysis
5
| As on 9th Jun 2023 CUE STOCK Price closed @ 3.71 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 4.61 & Strong Sell for SHORT-TERM with Stoploss of 8.41 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CUESTOCK Price
| Open | 3.78 | Change | Price | % |
| High | 3.87 | 1 Day | -0.06 | -1.59 |
| Low | 3.62 | 1 Week | -0.29 | -7.25 |
| Close | 3.71 | 1 Month | -0.59 | -13.72 |
| Volume | 247769 | 1 Year | -7.77 | -67.68 |
| 52 Week High 12.44 | 52 Week Low 2.23 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CUE Daily Charts |
CUE Intraday Charts |
Whats New @ Bazaartrend |
CUE Free Analysis |
|
|
CUE Important Levels Intraday
| RESISTANCE | 4.19 |
| RESISTANCE | 4.04 |
| RESISTANCE | 3.94 |
| RESISTANCE | 3.85 |
| SUPPORT | 3.57 |
| SUPPORT | 3.48 |
| SUPPORT | 3.38 |
| SUPPORT | 3.23 |
CUE Forecast April 2024
| 4th UP Forecast | 13.35 |
| 3rd UP Forecast | 10.26 |
| 2nd UP Forecast | 8.35 |
| 1st UP Forecast | 6.44 |
| 1st DOWN Forecast | 0.99 |
| 2nd DOWN Forecast | -0.93 |
| 3rd DOWN Forecast | -2.84 |
| 4th DOWN Forecast | -5.93 |
CUE Weekly Forecast
| 4th UP Forecast | 7.54 |
| 3rd UP Forecast | 6.31 |
| 2nd UP Forecast | 5.55 |
| 1st UP Forecast | 4.79 |
| 1st DOWN Forecast | 2.63 |
| 2nd DOWN Forecast | 1.87 |
| 3rd DOWN Forecast | 1.11 |
| 4th DOWN Forecast | -0.12 |
CUE Forecast2024
| 4th UP Forecast | 24.16 |
| 3rd UP Forecast | 17.6 |
| 2nd UP Forecast | 13.55 |
| 1st UP Forecast | 9.49 |
| 1st DOWN Forecast | -2.07 |
| 2nd DOWN Forecast | -6.13 |
| 3rd DOWN Forecast | -10.18 |
| 4th DOWN Forecast | -16.74 |
Cue Biopharma Inc ( NASDAQ USA Symbol : CUE )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CUE Business Profile
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate CUE-101, a fusion protein biologic that is in Phase I clinical trials designed to target and activate antigen-specific T cells for human papilloma virus driven cancers. The company offers CUE-102, a fusion protein biologic to target and activate antigen-specific T cells to fight cancers; CUE-103 would also leverage the IL-2 based CUE-100 framework and target an antigen to be selected in collaboration with LG Chem; CUE-200 framework that utilizes CD80 and/or 4-1BBL to reactivate exhausted T cells and design to enhance antigen-specific T cell for the treatment of chronic infectious diseases; and CUE-300 framework to target various autoimmune diseases. Cue Biopharma, Inc. has collaboration agreements with Merck Sharp & Dohme Corp. for the research and development of its proprietary biologics that target various autoimmune disease indications; LG Chem Life Sciences to the development of Immuno-STATs focused in the field of oncology; and Albert Einstein College of Medicine. The company was formerly known as Imagen Biopharma, Inc. and changed its name to Cue Biopharma, Inc. in October 2016. Cue Biopharma, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts. Address: 21 Erie Street, Cambridge, MA, United States, 02139
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service